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Noninvasive Imaging
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The abstract highlights for noninvasive imaging include
submissions related to echocardiography, nuclear cardiol-
ogy, magnetic resonance, and computer tomography. The
research presented at the 2003 American College of Cardi-
ology (ACC) Annual Scientific Sessions covered a broad
range of subjects and spanned the hierarchy of evaluation of
imaging methods, including demonstrations of technical
capacity and subsequent diagnostic performance, as well as
the impact on diagnostic and prognostic thinking, thera-
peutic outcome, and health-related outcomes. The primary
theme of the highlighted abstracts is expanded technical
capacity, both in the clinical arena as well as significant
extensions of noninvasive imaging methods to the cellular
and subcellular levels. A secondary theme is the impact of
established methods on diagnostic and prognostic thinking.
ECHOCARDIOGRAPHY
Research presented at this meeting included important
advances in the field of targeted microbubbles, the principles
of which are represented schematically in Figure 1. Echo
contrast bubbles have the following properties: first, they
move as red cells through the vascular bed; second, the
interface between the shell and the contained gas is very
echogenic, and the bubbles are easily imaged with ultra-
sound techniques; third, bubbles can be selectively destroyed
with exposure to ultrasound, typically of high intensity
and/or prolonged duration. These properties can be har-
nessed by attaching ligands to, or incorporating compounds
into, contrast bubbles to achieve imaging or therapeutic end
points.
Selective imaging is achieved by using a ligand with
specific affinity for cell types or biochemical compounds that
are markers of particular types of biologic activity. The
bubble-ligand complex can then be used as a probe because
the ligand directs the complex to the specified activity and
the bubble permits it to be imaged with ultrasound. Tar-
geted therapy can be achieved when a ligand with therapeu-
tic properties is selectively released at a target site by
directing ultrasound to that site, thereby destroying the
bubble-ligand complex.
Two animal studies which used imaging applications of
targeted microbubbles were presented by Leong-Poi et al.
Both studies used bubbles targeted to markers of angiogen-
esis ( integrins expressed in neovessels). In the first study,
angiogenesis was demonstrated in a rat model of hind limb
ischemia (1). When compared with control limbs, the
chronically ischemic hind limb demonstrated clear evidence
of angiogenesis. The same group used a similar approach to
demonstrate angiogenesis in both primary and metastatic
glioblastoma in a rat model (2).
Several studies reported the use of targeted bubbles for
therapeutic applications. Using a porcine model, Porter et
al. (3) demonstrated that formation of the c-myc protoon-
cogene, a mediator of intimal hyperplasia, was suppressed at
the site of stent and balloon injury by intravenous delivery of
anti-c-myc (antisense to the c-myc protooncogene) bound
to microbubbles. A long-term goal of this work is the use of
targeted microbubbles to reduce post-intervention resteno-
sis. In related work, Bekeredjian et al. (4) demonstrated the
feasibility of selective intravenous gene delivery to the heart,
brain, and pancreas. They incorporated recombinant adeno-
viruses or plasmids containing expression constructs of
beta-galactosidase and luciferase into contrast bubbles and
then released them at target sites with directed ultrasound-
mediated bubble destruction.
An understanding of the impact of bubble destruction on
local tissue is important to ensure that therapeutic applica-
tions minimize adverse events and to optimize the time
course of ligand delivery to the perivascular space. Work
presented by Vancraeynest et al. (5) built on earlier studies
from the same group which had demonstrated time- and
energy-dependent functional and structural myocardial al-
terations in rats exposed to myocardial contrast echocardi-
ography. Their hypothesis that these alterations might have
an ischemic origin was supported by the current study,
which demonstrated time- and energy-dependent
“ischemic-like” ST-T changes in this model. The greatest
ST-T elevation occurred in the setting of the most pro-
longed and the highest powered myocardial echocardio-
graphic ultrasound exposure.
In related studies, Li et al. (6) used a rat model in which
extravasation of Evans blue was used as a marker of coronary
microvascular leakage. They demonstrated that the degree
of microvascular leakage was directly related to ultrasound
transmit energy. In this study, the duration of exposure was
not varied. In a second study using ultrasound of high power
(7), extravasation of Evans blue was demonstrated immedi-
From the Division of Cardiology, Hartford Hospital, University of Connecticut
School of Medicine, Hartford, Connecticut.
385JACC Vol. 42, No. 2, 2003 Gillam
July 16, 2003:375–93 ACC 2003 Annual Session Highlights
ately after contrast echocardiography. However, this rapidly
diminished over time with evidence of return of microvas-
cular integrity by 20 min. This suggests that the time
window for delivery of therapeutic agents into the intersti-
tium may be narrow although potentially manipulated by
changing the duration and energy of ultrasound exposure.
In the clinical arena, two studies (8,9) presented prelim-
inary work with real-time three-dimensional ultrasound
echocardiography. This methodology, currently limited to
imaging, allows real-time acquisition and display of three-
dimensional images and creates an archive that can be easily
and rapidly sliced and rotated to display cardiac anatomy
and function from different vantage points. The preliminary
experience presented at this meeting suggests that major
Figure 1. Schematic representation of method in which targeted microbubbles may be used for imaging and therapeutic applications. White spheres 
microbubbles; yellow tags  ligands.
Figure 2. Reduction in left ventricular systolic function (measured with magnetic resonance strain methods) versus reduction in myocardial blood flow.
Subjects are grouped according to the transmural extent of necrosis and color coded. Data points represent mean SD values. See text for details. Modified
and reprinted with permission of the authors.
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applications are likely to be the assessment of valvular and
ventricular structure and function.
NUCLEAR CARDIOLOGY
The potential of extending nuclear imaging methods to the
cellular and subcellular level was also demonstrated at ACC
2003. 99mTc-annexin V has a high affinity for phosphati-
dylserine that is exteriorized on apoptotic cells surfaces.
Johnson et al. (10) and Hartung et al. (11) both used this
agent in animal models to demonstrate the feasibility of
imaging vascular plaque apoptosis associated with vulnera-
ble plaque. The study by Hofstra et al. (12) suggested that
phosphatidylserine that is exteriorized during ischemia may
subsequently be re-interiorized after perfusion. These au-
thors suggest, therefore, that imaging with annexin V may
provide a novel approach to define ischemic memory.
Two clinical studies used nuclear methods to address the
issue of the prevalence of myocardial perfusion abnormali-
ties in asymptomatic diabetics. In a follow-up to a previous
study which had shown a high prevalence of abnormal scans
in asymptomatic diabetics referred for screening stress single
photon emission computed tomography (SPECT), Rajago-
palan et al. (13) compared the results in community-based
versus referral subgroups. They demonstrated no significant
difference between the two groups in terms of the prevalence
of positive and high-risk scans, arguing that the initial
results did not reflect a referral bias of sending only the
highest risk patients for screening. In a related study, the
Detection of Ischemia in Asymptomatic type II Diabetics
(DIAD) investigators (14) reported abnormal adenosine
SPECT studies in 22% of subjects between the ages of 50
and 75 years (16% had perfusion abnormalities). It is
important to note that neither of these studies was truly a
population survey. However, both speak to the high prev-
alence of abnormal perfusion scans and, by extrapolation,
asymptomatic coronary disease in diabetics and support the
concept that these patients should be screened.
MAGNETIC RESONANCE
In an elegant human study, Gerber et al. (15) used a variety
of magnetic resonance methods to explore flow-function
and transmurality of necrosis relationships in patients with
chronic ischemic dysfunction. In the clinical assessment of
myocardial viability, it is generally thought that myocardial
stunning is characterized by perfusion-function mismatch,
whereas hibernating myocardium is typically associated with
perfusion-function match. The authors of this study mea-
sured myocardial blood flow, left ventricular function (myo-
cardial tagging strain methodology), and the transmural
extent of necrosis (based on the extent of hyperenhance-
ment). Ammonia positron emission tomography scans pro-
vided a secondary index of perfusion. The results are
summarized in Figure 2. The line of identity represents the
situation in which there would be a perfect flow-function
match. The data points circled in the lower right corner
demonstrate flow-function relationships for differing de-
grees of transmural necrosis. With progressive increases in
the degree of transmural necrosis, there is a transition from
the greatest flow-function mismatch towards improved
flow-function matching. This suggests that dysfunctional
myocardium demonstrating perfusion-function match is
associated with significant degrees of necrosis.
In another clinical magnetic resonance study, Hirsch et
al. (16) used magnetic resonance measures of infarct size,
left ventricular volume, and sphericity to determine the
degree of left ventricular remodeling as a function of
myocardial infarction size and patient age. They demon-
strated that remodeling (based on end-systolic volumes) was
Figure 3. Representative coronary angiograms obtained with 16-slice computed tomography. Provided by Dr. S. Schroeder (17).
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greatest in patients with the largest infarcts. Further, pa-
tients older than 60 years of age had a much greater
tendency to remodel than younger patients.
COMPUTED TOMOGRAPHY
Noninvasive coronary angiography has long been one of the
holy grails of non-invasive imaging. Two studies (17,18)
reported the initial experience with coronary angiography
obtained with 16-slice computed tomography and demon-
strated the feasibility of delineating stenosis in vessels as
small as 1.5 mm. Using conventional cineangiography as a
gold standard, both groups demonstrated sensitivities of
88% to 90% and specificities of 90% to 95%. A representa-
tive image provided by Dr. Schroeder (17) is shown in
Figure 3.
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Valvular Heart Disease
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Valvular heart disease was the focus of many exciting
presentations at the American College of Cardiology Sci-
entific Sessions in 2003. Traditional concepts related to
“degenerative” native and prosthetic valve disease are being
challenged, our surgical approaches are improving, and we
are beginning to see over the horizon at the possibilities for
percutaneous approaches to valve replacement and repair.
The role for cholesterol and inflammation in the devel-
opment of calcific aortic stenosis (AS) continues to evolve.
An estimated 2% to 9% of the elderly have calcific AS (1,2),
and they share both similar risk factors with those suffering
from atherosclerosis (3,4) and pathophysiologic mecha-
nisms that result in calcification (5). Of the many abstracts
investigating this, Fondard et al. (6) presented evidence for
an increase in matrix metalloproteins in AS. Matrix metal-
loproteins are proteolytic enzymes that lead to the degrada-
tion of the extracellular matrix; overexpression has been
associated with a variety of processes, most notably osteo-
arthritis (7). That tumor necrosis factor (TNF)-alpha may
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